Noble Corporation (NE)
NYSE: NE
· Real-Time Price · USD
29.25
0.95 (3.36%)
At close: Sep 24, 2025, 3:59 PM
29.50
0.84%
After-hours: Sep 24, 2025, 07:12 PM EDT
3.36% (1D)
| Bid | 29 |
| Market Cap | 4.65B |
| Revenue (ttm) | 3.45B |
| Net Income (ttm) | 309.04M |
| EPS (ttm) | 1.9 |
| PE Ratio (ttm) | 15.4 |
| Forward PE | 25.98 |
| Analyst | Hold |
| Dividends | $3 |
| Ask | 29.6 |
| Volume | 2,183,957 |
| Avg. Volume (20D) | 2,562,169 |
| Open | 28.53 |
| Previous Close | 28.30 |
| Day's Range | 28.53 - 29.64 |
| 52-Week Range | 17.40 - 37.99 |
| Beta | 1.12 |
| Ex-Dividend Date | Sep 4, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNoble Corporation is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+2.08%
Noble shares are trading higher after the company ...
Unlock content with
Pro Subscription
4 months ago
+7%
Noble shares are trading higher after the company reported better-than-expected Q1 sales results.
3 weeks ago · proactiveinvestors.com
MustGrow Biologics' early TerraSante success signals market potential, Noble analysts sayNoble Capital Markets analysts have highlighted MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)'s growing commercial traction following the company's second quarter results. The analysts pointed to...
